论文部分内容阅读
慢性丙型肝炎(Chronic hepatitis C,CHC)是由丙型肝炎病毒(HCV)感染引起的一种慢性感染性肝脏疾病。HCV可引起肝脏损害,如肝脂肪变、肝硬化、肝细胞癌外,还可引起肝脏外组织损害。由于肝脏在血糖代谢中起重要作用,近年来的研究又发现慢性HCV感染者糖尿病发病率增多,HCV感染可能导致糖尿病特别是2型糖尿病的发生,即肝源性糖尿病,它是胰岛素抵抗和分泌进行性损害的共同结果。同时由于肝脏是葡萄糖代谢的重要器官,糖尿病反过来又可加重肝脏的损害,造成恶性循环,加速了丙肝患者肝硬化、肝癌进度,成为威胁生命的重要因素。特别是在治疗和护理的过程中,两种疾病之间还存在着矛盾点,如何将两病联系到一起进行治疗和护理从而提高患者生命质量现已成为医护工作者共同面临的难题。因此如何早期发现DM,早期治疗成为CHC患者提高生命质量的关键因素之一。
Chronic hepatitis C (CHC) is a chronic infectious liver disease caused by the hepatitis C virus (HCV) infection. HCV can cause liver damage, such as liver steatosis, cirrhosis, hepatocellular carcinoma, but also can cause extrahepatic tissue damage. As the liver plays an important role in blood glucose metabolism, recent studies have found that the incidence of diabetes is increased in patients with chronic HCV infection. HCV infection may lead to the development of type 2 diabetes, especially type 2 diabetes, which is insulin resistance and secretion The common result of progressive damage. At the same time as the liver is an important organ of glucose metabolism, diabetes in turn can aggravate the damage of the liver, resulting in a vicious cycle, accelerating the progress of liver cirrhosis and liver cancer in hepatitis C patients, becoming an important threat to life. Especially in the process of treatment and nursing, there are contradictions between the two diseases. How to link the two diseases together for treatment and nursing to improve the quality of life of the patients has now become a common problem for medical workers. Therefore, early detection of DM, early treatment of CHC patients to improve quality of life of one of the key factors.